Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Neoplasm of mature B-cells · Aggressive B-cell non-Hodgkin lymphoma
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.
-
High grade B-cell lymphoma 184 trials
-
Primary mediastinal large B-cell lymphoma 175 trials
-
Plasmablastic lymphoma 20 trials
-
Primary effusion lymphoma 18 trials
-
Lymphomatoid granulomatosis 3 trials · 7 incl. sub-types Sub-types →
-
ALK-positive large B-cell lymphoma 5 trials
-
Intravascular large B-cell lymphoma 4 trials
-
EZB diffuse large B-cell lymphoma 0 trials · 2 incl. sub-types Sub-types →
-
A53 diffuse large B-cell lymphoma 0 trials
-
BN2 diffuse large B-cell lymphoma 0 trials
-
N1 diffuse large B-cell lymphoma 0 trials
-
ST2 diffuse large B-cell lymphoma 0 trials
-
Liver diffuse large B-cell lymphoma 0 trials